NVCR Net Margin
-21.25%TTM
Period ending:
NVCR FY Net Margin%
94.11%-836.99%
2013-12-312025-12-31
Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.
NVCR net margin history
Net income as a percentage of revenue. The available annual fiscal periods series contains 13 observations from Dec 31, 2013 to Dec 31, 2025.
| Period ending | Net Margin |
|---|---|
| -20.7868% | |
| -27.8621% | |
| -40.6494% | |
| -17.2047% | |
| -10.9061% | |
| 4.0067% | |
| -2.058% | |
| -25.6215% | |
| -34.8322% | |
| -159.064% | |
| -337.2352% | |
| -520.8651% | |
| -746.8868% |
Compare net margin
Other companies in Health Care. Each page shows its own reporting periods and currency.
- Guardant Health Inc (GH) net margin
- Bridgebio Pharma Inc (BBIO) net margin
- Brightspring Health Services Inc (BTSG) net margin
- Madrigal Pharmaceuticals Inc (MDGL) net margin
- Ensign Group Inc (ENSG) net margin
- Glaukos Corp (GKOS) net margin
- Krystal Biotech Inc (KRYS) net margin
- Twist Bioscience Corp (TWST) net margin
Compare all covered stocks by net margin →
All NVCR financial metrics · NVCR stock overview · How to interpret financial metrics
